# 1. Financial Performance ## A. Key Figures * **Gross Written Premium (GWP):** **₹20,369 Cr** FY26 (+16%) · **₹6,259 Cr** Q4 FY26 (+17%) * **Retail Health Growth:** **30.2%** H2 FY26 · **~20%** FY26 · **38%** Q4 Fresh Retail * **Underwriting Profit:** **₹206 Cr** FY26 (vs. loss) · **₹186 Cr** Q4 FY26 (+200%) * **Profit After Tax (PAT):** **₹911 Cr** FY26 (+16%) · **₹1,222 Cr** FY26 Normalized * **Combined Ratio:** **98.8%** FY26 (-230 bps) · **95.7%** Q4 FY26 (-270 bps) ## B. Premium Growth * **Market Outperformance:** Retail health premiums significantly outpaced the broader non-life industry growth, driven by a robust **93-94% new-to-insurance mix**. * **Value-Led Strategy:** Fresh business growth is substantially higher than volume growth, signaling a strategic shift toward value driven by consistent pricing actions. * **Revenue Recognition Lag:** Net Earned Premium (NEP) growth currently trails GWP due to the rising popularity of long-term policies, creating a temporary **100-150 bps shift** in the premium mix. ## C. Underwriting Profitability & Combined Ratio * **Operational Turnaround:** The business achieved a full-year underwriting profit, representing a massive **₹371 Cr** year-over-year improvement. * **Efficiency Gains:** Combined ratio compression was fueled by simultaneous reductions in loss and expense ratios, though management cautions that loss ratios should be viewed over long-term cycles. * **Bottom-line Resilience:** Annual PAT growth remained positive despite a **₹127 Cr** marked-to-market loss, supported by disciplined underwriting. ## D. Investment Yields * **Yield Stability:** Normalized profitability was bolstered by a steady **8%** investment yield on the float. --- # 2. Distribution & Agency ## A. Key Figures * **Proprietary Channel Contribution:** **>90%** of retail business * **Agent Workforce:** **8 Lakh+** current count · **10 Lakh** 2-year target * **Agent Productivity Growth:** **+37%** fresh business · **+18%** total business * **Distributor Income Growth:** **>50%** post-GST announcement ## B. Proprietary Channels & Strategy * **Dominant Distribution Mix:** Retail business is almost entirely driven by internal channels, facilitating deeper penetration into non-urban markets. * **Aggressive Workforce Scaling:** Management plans to onboard **1 lakh agents annually**, utilizing "ring-fencing" and best-in-class offerings to ensure retention against competitive pressures. * **Strategic Geographic Selection:** Growth is being moderated in specific markets to prioritize long-term profitability over volume. ## C. Agent Productivity & Economics * **Efficiency Gains:** Robust double-digit productivity improvements are being fueled by a technology-led L&D transformation and regular upskilling. * **Commission Optimization:** The commission ratio has improved following a **reduction in senior citizen commissions** (effective April FY25) and enhanced sales manager output. * **Rising Partner Income:** Significant growth in distributor earnings since the GST announcement underscores the health of the agency ecosystem. ## D. Digital Sourcing * **Bima Sugam Outlook:** While the platform is expected to offer lower-cost insurance plans than traditional channels, it is not anticipated to be a zero-cost environment for consumers. --- # 3. Claims & Operations ## A. Key Figures * **IND AS Expense Ratio:** **30.1%** FY26 (-30 bps) ## B. Loss Ratio Dynamics * **Sustained Improvement:** Achieved third consecutive quarter of loss ratio contraction through analytics-led pricing, strengthened underwriting, and a wellness-based consumer ecosystem. [5, 7, 20] * **Portfolio Recalibration:** Management is targeting a return to historical levels of **65%-66%** by optimizing the retail mix and reducing exposure to the Group Health business. * **Underwriting Drivers:** Recent gains are attributed to a cohort-based pricing strategy launched five quarters ago and improved sourcing quality across both renewal and fresh books. * **Frequency Trends:** Observed a notable reduction in claims frequency during Q4, supported by internal interventions such as Telemedicine and Home Healthcare. [14, 15] ## C. Claims Severity & Fraud Management * **Severity Benchmarking:** Claims severity is currently trending in the **high single digits**, serving as the primary anchor for ongoing pricing adjustments and forecasting. [12, 13] * **Cost Containment:** Actively mitigating severity through hospital partner negotiations and increased utilization of preferred provider networks. * **FWA Initiatives:** Leveraging scale to deploy advanced data analytics for Fraud, Waste, and Abuse (FWA) management to maintain a competitive edge over industry peers. ## D. Platform Efficiency * **Operating Leverage:** Expense ratio improved despite an **Rs. 80 crore** headwind from GST and Labor Code factors, reflecting disciplined cost control. * **Digital Migration:** Transition to the Medi Assist platform for claims processing is nearing completion, with the final product phase expected to migrate by **end of the current quarter**. * **Service Innovation:** Expansion of home-based solutions and Telemedicine for high-volume cases (e.g., infectious diseases) is designed to enhance CX while maintaining low servicing costs. * **Regulatory Infrastructure:** Participating in GI Council and IRDAI initiatives, including common hospital empanelment, to reduce external volatility in loss ratios. --- # 4. Customer & Product ## A. Key Figures * **Retention Metrics:** **92%** Retail Claim Settlement Ratio (+3%) · **99%** Renewal Ratio (+2%) · **62** Company NPS (+8 pts) * **Persistency:** **86%–87%** Volume-based retention · **300 bps** GWP improvement in renewals * **Customer Mix:** **94%** New-to-insurance (H2 FY26) · **93%** Fresh GWP from new-to-insurance * Digital & Wellness: **14 Mn+** App downloads · **1.5 Mn+** Monthly active users · **90,000+** Home Healthcare calls * **Segment Mix:** **20%** Senior Citizen portfolio · **78%** SME share of Group Health (vs. 58% FY25) ## B. Retention & Customer Value * **Enhanced Loyalty:** Record renewal and settlement ratios, alongside a best-in-class grievance ratio, underscore industry-leading persistency. * **Value Migration:** Renewal growth is increasingly driven by "upselling," with customers opting for **higher sum assured levels** and **additional riders**. * **Policyholder Behavior:** Despite temporary renewal delays caused by tax policy shifts, the underlying volume-based retention saw a steady annual uptick. ## C. Acquisition Strategy * **Quality-First Sourcing:** Management is intentionally prioritizing a "new-to-insurance" mix over the portability market to build a sustainable, long-term franchise. * **Market Positioning:** Fresh premium is overwhelmingly dominated by first-time buyers, reflecting a strategic focus on market expansion rather than price-sensitive switching. ## D. Wellness & Digital Ecosystem * **Engagement Scaling:** The mobile app has become the primary interface for claims and renewals, supported by a massive surge in wellness program consumption. * **Clinical Interventions:** Significant scaling of Telemedicine and Home Healthcare serves as a structural tool to mitigate seasonal claim volatility and fraud. ## E. Segment Performance * **Group Health Pivot:** A deliberate shift toward the **SME segment** has fundamentally reconfigured the Group portfolio to improve loss ratios. * **Growth Dynamics:** While the retail segment grew **19%** in Q4, it trailed the broader industry average of **29%**, reflecting a calibrated, risk-first approach. * **Strategic Shifts:** Increasing adoption of long-term policies is expected to provide long-term stability for the book, despite a short-term lag in premium recognition. --- # 5. Strategic Initiatives ## A. Key Figures * **PAT (FY26):** **₹1,222 Cr** Normalized framework (+45%) * **Return on Equity (ROE):** **13.1%** FY26 (vs. 10.1% YoY) · **Mid-to-high teen** Long-term target * **Market Share:** **31.3%** Retail Health leadership (FY26) · **30%+** Category share * **Digital Adoption:** **95%** Fresh premiums collected digitally * **Network Scale:** **2.8 Cr** Lives covered · **15,000+** Hospital partners · **900+** Offices ## B. ROE Recalibration & Strategy * **Strategic Pivot:** FY26 serves as a "recalibration year" focusing on underwriting discipline, claims management, and operating efficiency to strengthen core levers. * **Normalized Performance:** Under a steady-state **8% investment yield** framework, the company demonstrated significant bottom-line expansion and improved capital efficiency. * **Sustainable Growth Mandate:** Management is targeting high-teen growth and mid-to-high teen ROE by prioritizing proprietary channels and preferred customer segments. ## C. Technology & Healthcare Integration * **Digital Transformation:** Robust digital collection rates reflect successful platform modernization, workflow automation, and AI deployment. * **Care Management:** Expansion of Home Health Care and Telemedicine is being leveraged to improve customer convenience and manage infection-related cases more effectively. * **Industry Collaboration:** Active participation as a shareholder in the **Bima Sugam** platform to support centralized insurance service streamlining. ## D. Market Leadership * **Dominant Retail Franchise:** Maintained a commanding lead in the retail health segment, supported by a granular distribution network and **75+ partnerships**. * **Growth Outlook:** Projections indicate a steady growth rate exceeding **39%** for FY26, underpinned by a risk-first approach and customer-centric execution. --- # 6. Regulatory & Market Risks ## A. Key Figures * **Net Income:** **-₹55 Cr** Q4 FY26 (vs. ₹271 Cr profit YoY) * **Investment Impact:** **-₹558 Cr** Marked-to-market loss on equity portfolio ## B. Accounting Transitions * **IND AS Readiness:** Full implementation of new accounting standards mandated for **April 1, 2026**; internal audits and business decisions are already aligned with these principles. * **Reporting Normalization:** Transitioning to **1/n measures** next fiscal year to eliminate current reporting distortions caused by the shift toward long-term policy sales. * **Regulatory Leadership:** Active participation in the **PIR (Public Information Record)** initiative, with the CTO joining the working group to standardize industry-wide underwriting data. ## C. Expense & Competitive Positioning * **Regulatory Glide Path:** Operations currently tracking toward the **March 2026** deadline for Expense of Management (EoM) compliance following the 2023 regulatory overhaul. * **Arbitrage Mitigation:** Strategic focus on improving expense operating ratios to counter potential cross-subsidization advantages held by multi-line insurers. ## D. Market Dynamics * **Macro Tailwinds:** Sector entering a structural growth phase supported by the **GST exemption on Retail Health insurance** and the national "Insurance for All" 2047 vision. * **Volatility Impact:** Bottom-line performance was significantly pressured by substantial marked-to-market equity losses triggered by geopolitical tensions, despite underlying operational gains. --- # 7. Guidance & Outlook ## A. Margin Sustainability * **Loss Ratio Trajectory:** Management expects sustained annual improvement in loss ratios, fueled by higher earnings from fresh retail business and strategic portfolio repricing. * **Profitability Over Volume:** The core strategy prioritizes high-margin geographies and specific consumer cohorts over aggressive market share expansion. * **Combined Ratio Stability:** Current pricing is deemed sufficient to meet target combined ratios through **FY27**, with no major repricing required beyond routine adjustments. * **P&L Realization:** Strategic measures are expected to manifest progressively in financial results, reflecting the long-tail nature of the insurance business. ## B. Pricing Strategy * **Aggressive Book Repricing:** Plans are in place to reprice approximately **80% of the book** between **Q4 and Q1** to accelerate future earnings growth. * **Severity-Linked Adjustments:** To protect margins, premium increases may slightly exceed claims severity, which is currently rising due to higher-quality medical treatments. * **Data-Driven Corrections:** Pricing actions remain strictly tied to actuarial principles and product performance rather than external factors like GST. * **Dynamic Rate Optimization:** The company is shifting toward annual price increases optimized by customer wellness behaviors and specific health conditions. * **Regulatory Compliance:** Management anticipates no regulatory friction regarding hikes, noting that **GST benefits are fully passed on** to consumers and increases are data-justified.